Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Response to: Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination

Response to: Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination Acta Neurologica Belgica https://doi.org/10.1007/s13760-023-02245-7 LE T TER TO  THE   EDITOR Response to: Correspondence on Bell’s palsy as an adverse event following COVID‑19 vaccination 1 2 2 1 Sohyeon Kim  · Minsung Kang  · Jin‑Sung Park  · Hung Youl Seok Received: 9 March 2023 / Accepted: 13 March 2023 © The Author(s) under exclusive licence to Belgian Neurological Society 2023 To the Editor, Furthermore, our findings will remain as simple observa - tions with hypothetical explanations until the definite cau- We would like to thank Drs. Kleebayoon and Wiwanitkit sality and pathogenic mechanism is established even though [1] for their interest in our recently published article [2]. In many previous studies have reported the increased incidence the era of COVID-19, vaccination safety has been an impor- of BP among vaccinated individuals [6, 7]. Therefore, poten- tant and noteworthy issue. The purpose of our study was to tial heterogeneity of the study population and undefined evaluate the risk and clinical characteristics of Bell’s palsy causal relationships between BP and COVID-19 vaccination (BP) after COVID-19 vaccination. were stated as major limitations in our study. Several studies have been conducted to determine the We agree with the idea that a prospective study with con- factors influencing the occurrence of adverse events http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Neurologica Belgica Springer Journals

Response to: Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination

Download PDF
2 pages

Loading next page...
 
/lp/springer-journals/response-to-correspondence-on-bell-s-palsy-as-an-adverse-event-DLyinGEV08
Publisher
Springer Journals
Copyright
Copyright © The Author(s) under exclusive licence to Belgian Neurological Society 2023
ISSN
0300-9009
eISSN
2240-2993
DOI
10.1007/s13760-023-02245-7
Publisher site
See Article on Publisher Site

Abstract

Acta Neurologica Belgica https://doi.org/10.1007/s13760-023-02245-7 LE T TER TO  THE   EDITOR Response to: Correspondence on Bell’s palsy as an adverse event following COVID‑19 vaccination 1 2 2 1 Sohyeon Kim  · Minsung Kang  · Jin‑Sung Park  · Hung Youl Seok Received: 9 March 2023 / Accepted: 13 March 2023 © The Author(s) under exclusive licence to Belgian Neurological Society 2023 To the Editor, Furthermore, our findings will remain as simple observa - tions with hypothetical explanations until the definite cau- We would like to thank Drs. Kleebayoon and Wiwanitkit sality and pathogenic mechanism is established even though [1] for their interest in our recently published article [2]. In many previous studies have reported the increased incidence the era of COVID-19, vaccination safety has been an impor- of BP among vaccinated individuals [6, 7]. Therefore, poten- tant and noteworthy issue. The purpose of our study was to tial heterogeneity of the study population and undefined evaluate the risk and clinical characteristics of Bell’s palsy causal relationships between BP and COVID-19 vaccination (BP) after COVID-19 vaccination. were stated as major limitations in our study. Several studies have been conducted to determine the We agree with the idea that a prospective study with con- factors influencing the occurrence of adverse events

Journal

Acta Neurologica Belgica – Springer Journals

Published: Mar 20, 2023

References

  • Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination
    Kleebayoon, A; Wiwanitkit, V
  • Risk and characteristics of Bell’s palsy in adults as an adverse event following COVID-19 vaccination: a retrospective study
    Kim, S; Kang, M; Park, JS; Seok, HY
  • Adverse events following administration of COVID-19 vaccines in Saudi Arabia
    Alqahtani, S; Jokhdar, H; Al-Tawfiq, JA; Al-Otaibi, S; Assiri, A; Almudarra, S
  • Analysis of COVID-19 vaccine type and adverse effects following vaccination
    Beatty, AL; Peyser, ND; Butcher, XE; Cocohoba, JM; Lin, F; Olgin, JE
  • Factors associated with development of adverse events after taking COVID-19 vaccine in a tribal state of India: regression analysis
    Kujur, M; Kiran, KA; Nag, AR; Soren, SK; Kujur, A
  • Bell’s palsy and SARS-CoV-2 vaccines-an unfolding story
    Cirillo, N; Doan, R
  • Bell’s palsy and SARS-CoV-2 vaccines
    Ozonoff, A; Nanishi, E; Levy, O